CZL gets more validation on deeps drilling

|

Published 24-MAY-2016 12:56 P.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Consolidated Zinc (ASX:CZL) has continued to hit high grades as part of its campaign to hit deeper horizons at its Plomosas zinc mine in Mexico – with grades of 48% hit.

It had previously released some results from the ‘Level 7 Deeps’ drilling campaign, but the latest results from assays back up the earlier bullish sentiments.

It told its shareholders that grades of up to 41.94% zinc and 16.9% lead had been hit in the latest drill hole – backing up previous hits of up the 48% Zn.

The latest drillhole, LV7DD018, was terminated at 62.5m having encountered “massive sulphide mineralisation” from 57.6m.

The assay results on their own don’t tell the whole picture, but given previous results had also hit high grades at Level 7, CZL will likely feel more validated about its decision to explore Level 7.

“Another fantastic interception, further confirming the high grade nature of the mineralisation below Level 7,” managing director Will Dix said.

With the latest hole assay now back, CZL has wrapped up the latest batch of drilling but given it’s now drilling just 200m to the north it is expected to release more drill results as this continues.

About CZL and Plomosas

The main game for CZL is the Plomosas Zinc Project in Mexico.

It has been mined to the tune of 2 million tonnes of ore in the past, with an average zinc + lead grade of 22%. It has mined down to 270m below the surface.

CZL currently has a 51% stake in the project, but is aiming to increase this to above 80%.

It covers 11 exploration concessions covering over 3000 hectares in the northern Mexican state of Chihuahua, about two hours flight from Dallas to the north east.

CZL is aiming to initially focus on a 200tpd processing plant which is already present on site, using cashflow from early production to fund exploration.

Graphic showing drilling at the Plomosas project

Graphic showing drilling at the Plomosas project

tags

ZINC


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X